Comparing intensity-modulated proton therapy with intensity-modulated photon therapy for oropharyngeal cancer: The journey from clinical trial concept to activation Journal Article


Authors: Frank, S. J.; Blanchard, P.; Lee, J. J.; Sturgis, E. M.; Kies, M. S.; Machtay, M.; Vikram, B.; Garden, A. S.; Rosenthal, D. I.; Gunn, G. B.; Fuller, C. D.; Hutcheson, K.; Lai, S.; Busse, P. M.; Lee, N. Y.; Lin, A.; Foote, R. L.
Article Title: Comparing intensity-modulated proton therapy with intensity-modulated photon therapy for oropharyngeal cancer: The journey from clinical trial concept to activation
Abstract: Intensity-modulated proton therapy minimizes the incidental irradiation of normal tissues in patients with head and neck cancer relative to intensity-modulated photon (x-ray) therapy and has been associated with lesser treatment-related toxicity and improved quality of life. A phase II/III randomized trial sponsored by the US National Cancer Institute is currently underway to compare deintensification treatment strategies with intensity-modulated proton therapy vs intensity-modulated photon (x-ray) therapy for patients with advanced-stage oropharyngeal tumors. After significant input from numerous stakeholders, the phase III portion of the randomized trial was redesigned as a noninferiority trial with progression-free survival as the primary endpoint. The process by which that redesign took place is described here. © 2018 The Authors
Journal Title: Seminars in Radiation Oncology
Volume: 28
Issue: 2
ISSN: 1053-4296
Publisher: Elsevier Inc.  
Date Published: 2018-04-01
Start Page: 108
End Page: 113
Language: English
DOI: 10.1016/j.semradonc.2017.12.002
PROVIDER: scopus
PMCID: PMC5942581
PUBMED: 29735186
DOI/URL:
Notes: Review -- Export Date: 1 June 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Nancy Y. Lee
    870 Lee